Catalyze Partners, a prominent player in acquiring and commercializing cutting-edge technologies, has announced the acquisition of Axcend, LLC. The deal, which was finalized on July 15, 2024, marks a significant milestone for Catalyze Partners, enhancing its position in the analytical instrumentation and measurement sector. “This acquisition, identified and brought to us through our trusted partner network, highlights their confidence in our commercialization capabilities,” said Tricia D’Cruz, founder and Managing Director of Catalyze Partners. “Our acquisition of Axcend addresses a growing $5 billion market, which is crucial for industries such as pharmaceuticals, environmental monitoring, chemical manufacturing, oil & gas, and more.”
The acquisition includes Axcend’s innovative range of eco-friendly, compact, and portable HPLC instruments and accessories, known for their exceptional performance and reliability. The Focus LC, initially developed at Brigham Young University by renowned inventor Dr. Milton Lee, represents a major advancement in reducing the size, cost, and environmental footprint of traditional HPLC systems. This development aligns with industry demands for more compact, portable, and sustainable laboratory equipment.
“We are thrilled to collaborate with the experienced team at Catalyze Partners,” said Greg Ward, CEO of Axcend. “I am confident that this partnership will drive the development of cutting-edge solutions that push the boundaries of scientific analysis and help scientists tackle the most complex health and scientific challenges.”
launches scalable companies that accelerate commercialization of intellectual property sourced from the world’s most innovative global corporations, monetizing significant investments in innovation. With established internal and external funding networks and a leadership team made up of proven business operators, Catalyze commercializes untapped innovations to make the greatest impact and deliver the highest value to our stakeholders. Catalyze is the bridge between novel technologies and commercial markets that drive profits and investor returns.
